View Item 

Show simple item record

Form IV of carbamazepine

dc.contributor.authorLang, Meidongen_US
dc.contributor.authorKampf, Jeffrey W.en_US
dc.contributor.authorMatzger, Adam J.en_US
dc.date.accessioned2006-04-19T13:37:32Z
dc.date.available2006-04-19T13:37:32Z
dc.date.issued2002-04en_US
dc.identifier.citationLang, Meidong; Kampf, Jeff W.; Matzger, Adam J. (2002)."Form IV of carbamazepine." Journal of Pharmaceutical Sciences 91(4): 1186-1190. <http://hdl.handle.net/2027.42/34507>en_US
dc.identifier.issn0022-3549en_US
dc.identifier.issn1520-6017en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/34507
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11948557&dopt=citationen_US
dc.description.abstractCarbamazepine has been found to crystallize as a new polymorph that is stable at room temperature. We report the crystal structure of this C -centered monoclinic form (space group C 2/ c , cell parameters: a  = 26.609, b  = 6.9269, c  = 13.957, Β = 109.702), which consists of hydrogen bonded dimers with an anti -disposition. This represents the third modification of carbamazepine that has been crystallographically characterized, and the fourth for which cell parameters have been determined. Thus, it is designated as form IV of carbamazepine. Differences between the packing of the various polymorphs are discussed. © 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:1186–1190, 2002en_US
dc.format.extent120816 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherChemistryen_US
dc.subject.otherFood Science, Agricultural, Medicinal and Pharmaceutical Chemistryen_US
dc.titleForm IV of carbamazepineen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055en_US
dc.contributor.affiliationumDepartment of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055en_US
dc.contributor.affiliationumDepartment of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055 ; Department of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055. Telephone: 734-615-6627; Fax: 734-615-8553en_US
dc.identifier.pmid11948557en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/34507/1/10093_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/jps.10093en_US
dc.identifier.sourceJournal of Pharmaceutical Sciencesen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
10093_ftp.pdf
Size:
117.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.